Teva Pharmaceutical Industries LimitedTEVANYSE
LOADING
|||
Cash Generation Expanding
Trending higher, slight contraction.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$2.05B
Near historical average
Average (9y)
$1.87B
Historical baseline
Range
High:$4.77B
Low:$236.00M
CAGR
-9.0%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $2.05B | +143.4% |
| 2023 | $842.00M | -19.2% |
| 2022 | $1.04B | +341.5% |
| 2021 | $236.00M | -63.0% |
| 2020 | $638.00M | +52.3% |
| 2019 | $419.00M | -76.7% |
| 2018 | $1.79B | -31.8% |
| 2017 | $2.63B | -39.1% |
| 2016 | $4.32B | -9.4% |
| 2015 | $4.77B | - |